Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
Researchers at a quaternary academic medical center have developed a short-term workaround that they report is now reducing the institution’s consumption of Omnipaque (iohexol) by more than 50% without compromising care quality.
A federal judge has dismissed a class-action lawsuit filed by patients over a data breach at a four-location radiology practice and its countrywide parent company.
The FDA has OK’d two subsidiaries of Los Angeles-based RadNet to sell medical AI software—one product for diagnosing breast cancer, the other for streamlining MRI prostate reporting workflows.
A radiology practice with a national footprint has picked Fujifilm Healthcare Americas to supply workflow management software and related services across the practice’s growing enterprise.
The news comes after the New Hampshire Attorney General's Office issued a report that it objected to the merger on the basis that it violates New Hampshire law.
Of 1,000 patients injected with corticosteroids under fluoroscopic guidance at an academic medical center over a 4½-year period, only 10 experienced serious complications within a year.